eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
6.44
+0.24 (3.96%)
At close: Sep 18, 2026, 4:00 PM EDT
6.44
+0.01 (0.08%)
After-hours: Sep 18, 2026, 6:34 PM EDT
eXoZymes Market Cap
eXoZymes has a market cap or net worth of $59.73 million as of September 18, 2026. Its market cap has decreased by -47.72% in one year.
Market Cap
59.73M
Enterprise Value
55.16M
1-Year Change
-47.72%
Ranking
Category
Stock Price
$6.44
ChartMarket Cap Chart
Since November 13, 2024, eXoZymes's market cap has decreased from $70.30M to $59.73M, a decrease of -15.04%. That is a compound annual growth rate of -8.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 59.73M | -34.67% |
| Dec 31, 2025 | 91.42M | -41.85% |
| Dec 31, 2024 | 157.23M | 123.64% |
| Nov 13, 2024 | 70.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Impact BioMedical | 61.61M |
| MindWalk Holdings | 61.55M |
| INmune Bio | 60.50M |
| Heron Therapeutics | 59.94M |
| MiNK Therapeutics | 59.76M |
| Xilio Therapeutics | 59.22M |
| Dogwood Therapeutics | 58.47M |
| ImageneBio | 57.89M |